Uruguay progresses towards developing its first regulatory agency
Uruguay’s new left-wing coalition government took office in March 2025, under President Yamandu Orsi. Part of his new agenda has…
Pricing and Market Access
Navigating tariffs and diplomacy: the future of India-US pharmaceutical trade
The European Market Access Lag: 2021–2024
Trump revives plan for IRP use in US via MFN executive order
5EU Q1 2024 versus 2025: Pricing shifts, HTA outcomes, and innovative drug trends
First two medicinal products to undergo EU joint clinical assessments announced
Ukraine ramps up cost-containment measures to “stabilise” retail drug market
Vietnam eases foreign investment restrictions in amended pharmaceutical law
